Novel treatments of cervical cancer

International Journal of Gynecological Cancer

Volumn 6, Issue SUPPL. 1, 1996, Pages 18-27

  Mohamed, E ^a   Piamsomboom, S ^b   Kudelka, A P ^c   Kavanagh, J ^c  

^a AIN SHAMS UNIVERSITY   (Egypt)

^b MAHIDOL UNIVERSITY   (Thailand)

^c UNIVERSITY OF TEXAS   (United States)

Author keywords

Camptothecin; Cervix cancer; Papillomavirus; Taxane; Vaccine

Indexed keywords

ALKALOID; ALKYLATING AGENT; ALPHA2A INTERFERON; ANTIMETABOLITE; ANTINEOPLASTIC AGENT; ANTINEOPLASTIC ANTIBIOTIC; BLEOMYCIN; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; FLUOROURACIL; FUMAGILLOL CHLOROACETYLCARBAMATE; IFOSFAMIDE; IRINOTECAN; ISOTRETINOIN; LC 9018; METAL COMPLEX; PACLITAXEL; PICIBANIL; SCHIZOPHYLLAN; VINBLASTINE; VINCRISTINE; VIRUS VACCINE;

ALLERGIC REACTION; ALOPECIA; BONE MARROW SUPPRESSION; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; CONFERENCE PAPER; FEMALE; GASTROINTESTINAL TOXICITY; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; NEUROPATHY; PAPILLOMA VIRUS; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; UTERINE CERVIX CANCER; VACCINATION; WART VIRUS;

EID: 0029778923     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Asbury RF, Blessing TA, Soper JT. A Gynecologic Oncology Group phase II study of amonafide (NSC #308847) in squamous cell carcinoma of the cervix. Am J Clin Oncol 1994; 17: 125-8.
2. Smith HO, Stringer CA, Kavanagh JJ, et al. Treatment of advanced or recurrent squamous cell carcinoma of the uterine cervix with mitomycin-C, bleomycin, and cisplatin chemotherapy. Gynecol Oncol 1993; 48: 11-15.
3. Filtenborg TA, Hansen HH, Engelholm SA, et al. A phase II study of ifosfamide, carboplatin, and cisplatin in advanced and recurrent squamous cell carcinoma of the uterine cervix. Ann Oncol 1993; 4: 485-8.
4. Chambers SK, Lamb L, Kohorn EI, et al. Chemotherapy of recurrent/advanced cervical cancer: results of the Yale Unviersity PBM-PFU protocol. Gynecol Oncol 1994; 53: 161-9.
5. Bonomi P, Blessing J, Stehman F, et al. Randomized trial of three cisplatin dose schedules in squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study. J Clin Oncol 1985; 3: 1079-85.
6. Coleman R, Jarper P, Gallagher C, et al. A phase II study of ifosfamide in advanced and relapsed carcinoma of the cervix. Cancer Chemother Pharmacol 1986; 18: 280-3.
7. Zanetta G, Landoni F, Colombo A, et al. Three-year results after neoadjuvant chemotherapy, radical hysterectomy, and radiotherapy in locally advanced cervical carcinoma. Obstet Gynecol 1993; 82: 447-50.
8. Buxton EJ, Meanwell CA, Hilton C, et al. Combination bleomycin, ifosfamide, and cisplatin chemotherapy in cervical cancer. J Natl Cancer Inst 1989; 81: 359-61.